Most likely, the activated IL-33 signal in the ESCC might be an epiphenomenon that contributes to the tumor-derived esophageal inflammation and tumor angiogenesis, and immune suppression. This evidence concerns the gene IL33 and esophageal squamous cell carcinoma.